These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9129072)

  • 1. Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: correlation with response to interferon therapy.
    Polyak SJ; Faulkner G; Carithers RL; Corey L; Gretch DR
    J Infect Dis; 1997 May; 175(5):1101-7. PubMed ID: 9129072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
    Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
    J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of simple and complex hepatitis C virus quasispecies by heteroduplex gel shift analysis: correlation with nucleotide sequencing.
    Wilson JJ; Polyak SJ; Day TD; Gretch DR
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1763-71. PubMed ID: 9049381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy.
    Sandres K; Dubois M; Pasquier C; Payen JL; Alric L; Duffaut M; Vinel JP; Pascal JP; Puel J; Izopet J
    J Virol; 2000 Jan; 74(2):661-8. PubMed ID: 10623727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of hepatitis C virus quasispecies turnover during interferon-alpha treatment.
    von Wagner M; Lee JH; Rüster B; Kronenberger B; Sarrazin C; Roth WK; Zeuzem S
    J Viral Hepat; 2003 Nov; 10(6):413-22. PubMed ID: 14633173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy.
    Shindo M; Hamada K; Koya S; Arai K; Sokawa Y; Okuno T
    Hepatology; 1996 Nov; 24(5):1018-23. PubMed ID: 8903369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypervariable region 1 of hepatitis C virus genome and response to interferon therapy.
    Grahovac B; Bingulac-Popović J; Vucelić B; Hrstić I; Ostojić R; Drazić V; Balija M; Grgicević D
    Clin Chem Lab Med; 2000 Sep; 38(9):905-10. PubMed ID: 11097348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between diversity of hepatitis C virus quasispecies and viremia, activity of liver disease and response to interferon therapy].
    Tang X; Qian K; Yuan X; Johnson YN
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):128-31. PubMed ID: 12196822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C.
    González-Peralta RP; Qian K; She JY; Davis GL; Ohno T; Mizokami M; Lau JY
    J Med Virol; 1996 Jul; 49(3):242-7. PubMed ID: 8818972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep sequencing and phylogenetic analysis of variants resistant to interferon-based protease inhibitor therapy in chronic hepatitis induced by genotype 1b hepatitis C virus.
    Sato M; Maekawa S; Komatsu N; Tatsumi A; Miura M; Muraoka M; Suzuki Y; Amemiya F; Takano S; Fukasawa M; Nakayama Y; Yamaguchi T; Uetake T; Inoue T; Sato T; Sakamoto M; Yamashita A; Moriishi K; Enomoto N
    J Virol; 2015 Jun; 89(11):6105-16. PubMed ID: 25810555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of hepatitis C virus quasispecies during interferon treatment.
    Sakuma I; Enomoto N; Kurosaki M; Marumo F; Sato C
    Arch Virol; 1996; 141(10):1921-32. PubMed ID: 8920825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quasispecies nature of hepatitis C virus and response to alpha interferon: significance as a predictor of direct response to interferon.
    Toyoda H; Kumada T; Nakano S; Takeda I; Sugiyama K; Osada T; Kiriyama S; Sone Y; Kinoshita M; Hadama T
    J Hepatol; 1997 Jan; 26(1):6-13. PubMed ID: 9148023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical implications of HCV quasispecies heterogeneity in patients with hepatitis C].
    Tang X; Qian K; Lau JY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):173-5. PubMed ID: 11436653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep sequencing of hepatitis C virus hypervariable region 1 reveals no correlation between genetic heterogeneity and antiviral treatment outcome.
    Cortés KC; Zagordi O; Perlejewski K; Laskus T; Maroszek K; Bukowska-Ośko I; Pawełczyk A; Płoski R; Berak H; Horban A; Radkowski M
    BMC Infect Dis; 2014 Jul; 14():389. PubMed ID: 25016390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4.
    Zekri AR; El-Din HM; Bahnassy AA; Khaled MM; Omar A; Fouad I; El-Hefnewi M; Thakeb F; El-Awady M
    Virol J; 2007 Feb; 4():16. PubMed ID: 17300723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection.
    Chayama K; Tsubota A; Kobayashi M; Okamoto K; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Suzuki Y; Murashima N; Ikeda K; Kumada H
    Hepatology; 1997 Mar; 25(3):745-9. PubMed ID: 9049229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients.
    Kanazawa Y; Hayashi N; Mita E; Li T; Hagiwara H; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1994 Nov; 20(5):1121-30. PubMed ID: 7523271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease.
    Sherman KE; Rouster SD; Mendenhall C; Thee D
    Hepatology; 1999 Jul; 30(1):265-70. PubMed ID: 10385665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential sensitivity of hepatitis C virus quasispecies to interferon-alpha therapy.
    Mizokami M; Lau JY; Suzuki K; Nakano T; Gojobori T
    J Hepatol; 1994 Nov; 21(5):884-6. PubMed ID: 7890907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin.
    Abbate I; Lo Iacono O; Di Stefano R; Cappiello G; Girardi E; Longo R; Ferraro D; Antonucci G; Di Marco V; Solmone M; Craxì A; Ippolito G; Capobianchi MR
    J Hepatol; 2004 May; 40(5):831-6. PubMed ID: 15094232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.